14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GMAB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Genmab A/S stock downgraded from Buy Candidate to Hold/Accumulate after Thursday trading session.
(Updated on May 02, 2024)

Buy or Hold candidate since May 01, 2024 Loss -3.58% PDF

The Genmab A/S stock price fell by -3.58% on the last day (Thursday, 2nd May 2024) from $28.75 to $27.72. During the last trading day the stock fluctuated 3.11% from a day low at $27.42 to a day high of $28.27. The price has been going up and down for this period, and there has been a -2.15% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -128 thousand shares and in total, 662 thousand shares were bought and sold for approximately $18.36 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $27.51 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.10% during the next 3 months and, with a 90% probability hold a price between $28.09 and $32.75 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GMAB Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 0.95%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Genmab A/S stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $28.12 and $29.33. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Genmab A/S stock

Genmab A/S finds support from accumulated volume at $27.69 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.85 between high and low, or 3.11%. For the last week, the stock has had daily average volatility of 2.55%.

Our recommended stop-loss: $26.08 (-5.92%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (GMAB) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Genmab A/S to open at $27.80, and during the day (based on 14 day Average True Range), to move between $26.96 and $28.48, which gives a possible trading interval of +/-$0.759 (+/-2.74%) up or down from last closing price. If Genmab A/S takes out the full calculated possible swing range there will be an estimated 5.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $27.69 (0.11%) than the resistance at $28.23 (1.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Genmab A/S stock A Buy?

Genmab A/S holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.846 Hold/Accumulate Downgraded

Predicted Opening Price for Genmab A/S of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$27.80 ( 0.296%) $27.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GMAB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 28.66 3.38 %
R2 28.33 2.20 %
R1 28.13 1.47 %
Current price: 27.72
Support S1 27.48 -0.88 %
S2 27.27 -1.61 %
S3 26.95 -2.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 31.68 14.29 %
R2 28.75 3.72 %
R1 28.23 1.84 %
Current price 27.72
Support S1 27.69 -0.108%
S2 27.67 -0.180%
S3 27.59 -0.469%

FAQ

What is the symbol for Genmab A/S Stock and on which exchange is it traded?
The symbol for Genmab A/S is GMAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Genmab A/S Stock?
Genmab A/S holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Genmab A/S Stock?
Genmab A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genmab A/S Stock.

What's the current price of Genmab A/S Stock?
As of the end of day on the May 02, 2024, the price of an Genmab A/S (GMAB) share was $27.72.

What is the 52-week high and low for Genmab A/S Stock?
The 52-week high for Genmab A/S Stock is $42.70 and the 52-week low is $26.32.

What is the market capitalization of Genmab A/S Stock?
As of the May 02, 2024, the market capitalization of Genmab A/S is 18.123B.

When is the next earnings date for Genmab A/S?
The upcoming earnings date for Genmab A/S is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Genmab A/S

Genmab A/S Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esoph... GMAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT